Administration of safranal (0.25, 0.50, and 0.75 mg/kg/day, for 28 days) to diabetic rats increased CAT, SOD, and GSH levels in lung tissue and bronchoalveolar lavage fluid (BALF) and therefore protected lung tissue against lung damage caused by diabetes (201). This evidence concerns the gene SOD1 and diabetes mellitus.